Navigation Links
Haemonetics Reports 8% Revenue Growth for Second Quarter of Fiscal 2012, Adjusted Earnings Per Share of $0.72 and Updates Previously Provided Full Year Earnings Guidance
Date:10/31/2011

he software business, a key enabler of blood management solutions.
  • 22% revenue growth in diagnostic disposables products, with rapid uptake by leading US hospitals.
  • IMPACT® accounts increasing to 226 as more customers embrace the value of blood management.
  • The OrthoPAT recall remains on track with over 500 devices replaced to date.

  • In the quarter Haemonetics reported adjusted gross margin of 50.9%, down 170 basis points, and adjusted operating margin of 14.2%, down 270 basis points.  The Company's adjusted operating expenses were $65.8 million, up 10%.  Gross and operating margins were significantly impacted by the recall of OrthoPAT devices.  The negative impact on operating results associated with the OrthoPAT recall and other product quality initiatives was approximately 180 basis points of gross margin, $4 million of operating earnings or $0.12 per share in the quarter and 170 basis points of gross margin, $7 million of operating earnings or $0.20 per share year to date.

    Mr. Concannon added: "Despite the quality issues, the fundamentals of this business remain strong.  With the exception of OrthoPAT disposables, where the recall impacted revenues, we saw continued growth across all other product categories.  We continue to see a growing demand for our products and services as more customers seek economic savings and improved clinical outcomes using our blood management solutions."

    As noted, in the quarter revenues were $179.4 million, up 8%.  A break-down vs. the prior year quarter follows:

    Plasma

    Plasma disposables revenue was $64.4 million, up 14%.  Momentum continued in Haemonetics' plasma business in the quarter following a cyclical adjustment in the commercial Plasma business last year.  Plasma revenues are still being negatively impacted by a change in collection practices in Japan.

    Blood bank

    Platelet disposables revenue was $42.2 mil
    '/>"/>

    SOURCE Haemonetics Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Haemonetics Sets Date for Second Quarter Fiscal Year 2012 Earnings Release: October 31, 2011
    2. Haemonetics Sets Date for Fourth Quarter Fiscal Year 2011 Earnings Release: May 2, 2011
    3. Haemonetics to Present at J.P. Morgan Healthcare Conference
    4. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
    5. Pacira Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results
    6. ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020
    7. HeartWare International Reports Third Quarter 2011 Revenues of $21.3 Million; 54% Increase From $13.8 Million in Third Quarter 2010
    8. Uroplasty Reports Fiscal Second Quarter 2012 Financial Results
    9. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2011
    10. ERT Reports Third Quarter 2011 Operating Results
    11. CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/28/2015)... , May 28, 2015  Transportation Insight, ... announces winning the SDCE100 Award for the ... Demand Chain Executive magazine. Transportation Insight ... goods distributor quantify and control supply chain ... highly competitive market. Deploying Transportation Insight,s Enterprise ...
    (Date:5/28/2015)... and CAMBRIDGE, Mass., May 28, 2015 /PRNewswire/ ... investigating whether certain officers and directors ... duties to shareholders.  Eleven Biotherapeutics is a clinical-stage ... development of protein therapeutics to treat eye diseases, ... .   View this press release ...
    (Date:5/28/2015)... May 28, 2015 ... the addition of Jain PharmaBiotech,s new report  ...  to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... treatment is to match the right drug ... cases, even to design the appropriate treatment ...
    Breaking Medicine Technology:Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 2Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 3Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 4Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3
    ... Findings Show Survival Improvement with Lower Doses ... and other,Drugs in Newly Diagnosed Myeloma -, ... -- The,International Myeloma Foundation (IMF) - supporting ... myeloma patients,families, researchers and physicians - today ...
    ... April 5, 2007-- Stent thrombosis,restenosis and lifelong prescriptions. ... used as part of their heart,operations may be ... than medical experts have ever publicly acknowledged. Recent,articles ... drug-eluting stents continue to take blood thinners, they,could ...
    Cached Medicine Technology:The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 2The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 3New Cardioprotective Drug Could Provide Boost For Post-Bypass,Surgery Heart Health 2
    (Date:5/28/2015)... Three years ago, Dr. Jeffrey Gosin announced ... Vascular & Vein Center! Dr. Gosin’s center is ... is his mission to provide the highest quality care in ... Dr. Jeffrey Gosin is Board Certified in Surgery and Vascular ... and Jefferson Medical College. He completed a General Surgery residency ...
    (Date:5/28/2015)... (PRWEB) May 28, 2015 Dr. ... announced an exclusive deal to patients looking to undergo ... 1 through 30, patients will be able to get ... procedure, for just $600. For a three-treatment package, which ... treatment at no cost. , Dr. Juanita Jenyons, M.D., ...
    (Date:5/28/2015)... New Jersey Plastic Surgeon and “NJ Top ... With over 30 years of experience in the ... Dr. Rafizadeh knows what it takes to achieve that ... involves the principles of proportion, harmony and balance. ... comfort and personalized care from the moment a patient ...
    (Date:5/28/2015)... Lanham, Md. (PRWEB) May 28, 2015 ... Weekend Sweepstakes grand prize winner Robert Davis of Newark, ... Davis to congratulate him on winning the $10,000 sweepstakes ... winners from over 100,000 entries from around the country ... prize. The drawing took place on May 21 at ...
    (Date:5/28/2015)... (PRWEB) May 28, 2015 Are policies ... after a hospital stay triggering financial pain for seniors? ... American Journal of Managed Care set to figure out, ... recent federal rule change. , The study, “Observation Encounters ... A. Vashi, MD, MPH, examined how Medicare policies that ...
    Breaking Medicine News(10 mins):Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 2Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 3Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3
    ... DURHAM, N.C. -- A combination of two drugs shows promise ... originates in the eye and spreads to other organs, according ... Center researchers. , The drugs -- decitabine, which can ... an immune system protein -- may work together to cause ...
    ... laboratory of Dr. David R. Soll at the University ... field of cancer research, thanks to a new agreement ... part of the National Institutes of Health. , The ... for Cancer ( http://proteomics.cancer.gov ) recently selected the Developmental ...
    ... N.Y. (Tues., Sept. 4, 2007) Skin cancer is ... States, according to the Centers for Disease Control. But ... scientists must use model organisms, such as mice, to study ... Cold Spring Harbor Protocols ( www.cshprotocols.org ) includes ...
    ... in heart muscle, researchers say , , TUESDAY, Sept. 4 ... treatment in women who have angina, the piercing chest ... with heart disease, has been given fast-track status by ... will enroll about 300 women at 50 medical centers ...
    ... for stroke patients whove lose part of their vision? ... & Neural Repair explores that question. , The researchers ... the training would induce specific changes in the brains ... never in humans with brain injury. The home-based therapy ...
    ... 4 EaglePicher Corporation,(EaglePicher) today announced that it ... Boron, LLC (EP Boron) to,Ceradyne, Inc. (Nasdaq: ... Oklahoma, has produced enriched boron,isotopes and products containing ... materials industries. Its products include,isotope B11, an additive ...
    Cached Medicine News:Health News:Promising drug combination may help those with ocular melanoma that has spread 2Health News:Laboratory at UI plays major role in diagnosing cancer 2Health News:Laboratory at UI plays major role in diagnosing cancer 3Health News:A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols 2Health News:Trial to Test Gene Therapy for Angina in Women 2Health News:Trial to Test Gene Therapy for Angina in Women 3Health News:EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million 2
    ...
    ... Storage in bottom of tray ... etc. Anodized aluminum. Durable and ... rust. Security locks ensure against ... bumper guards hold instruments in ...
    Lance shaped gently curved tip. Flat serrated handle with polished finish....
    For use with E0828 A needle tip and E0828 B gouge tip. Round knurled with threaded ended for tips. Most popular size or model....
    Medicine Products: